Jarrom D[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2009	2
2016	2
2017	2
2020	1
2021	1
2022	1

Page 1

Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review.

Jarrom D, Elston L, Washington J, Prettyjohns M, Cann K, Myles S, Groves P. Jarrom D, et al. BMJ Evid Based Med. 2022 Feb;27(1):33-45. doi: 10.1136/bmjebm-2020-111511. Epub 2020 Oct 1. BMJ Evid Based Med. 2022. PMID: 33004426

The structures of E. coli NfsA bound to the antibiotic nitrofurantoin; to 1,4-benzoquinone and to FMN.

Day MA, Jarrom D, Christofferson AJ, Graziano AE, Anderson JLR, Searle PF, Hyde EI, White SA. Day MA, et al. Among authors: jarrom d. Biochem J. 2021 Jul 16;478(13):2601-2617. doi: 10.1042/BCJ20210160. Biochem J. 2021. PMID: 34142705 Free PMC article.

Mucosal melanoma of the upper airways tract mucosal melanoma: A systematic review with meta-analyses of treatment.

Jarrom D, Paleri V, Kerawala C, Roques T, Bhide S, Newman L, Winter SC. Jarrom D, et al. Head Neck. 2017 Apr;39(4):819-825. doi: 10.1002/hed.24652. Epub 2016 Nov 29. Head Neck. 2017. PMID: 27898196 Review.

Upper aerodigestive tract cancer: summary of the National Institute for Health and Care Excellence guidelines for England and Wales.

Paleri V, Kerawala C, Winter S, Robinson M, Jarrom D, Prettyjohns M; NICE Upper Aerodigestive Tract Cancer Guidelines Committee. Paleri V, et al. Among authors: jarrom d. Clin Otolaryngol. 2017 Feb;42(1):3-10. doi: 10.1111/coa.12764. Epub 2016 Nov 9. Clin Otolaryngol. 2017. PMID: 27862982 No abstract available.

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.

Vass SO, Jarrom D, Wilson WR, Hyde EI, Searle PF. Vass SO, et al. Among authors: jarrom d. Br J Cancer. 2009 Jun 16;100(12):1903-11. doi: 10.1038/sj.bjc.6605094. Epub 2009 May 19. Br J Cancer. 2009. PMID: 19455141 Free PMC article.

Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954.

Jarrom D, Jaberipour M, Guise CP, Daff S, White SA, Searle PF, Hyde EI. Jarrom D, et al. Biochemistry. 2009 Aug 18;48(32):7665-72. doi: 10.1021/bi900674m. Biochemistry. 2009. PMID: 19580253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results